NEGXF
Price
$0.20
Change
+$0.01 (+5.26%)
Updated
Apr 7 closing price
Capitalization
12.53M
NEUE
Price
$6.85
Change
-$0.00 (-0.00%)
Updated
Jun 13 closing price
Capitalization
52M
Interact to see
Advertisement

NEGXF vs NEUE

Header iconNEGXF vs NEUE Comparison
Open Charts NEGXF vs NEUEBanner chart's image
Nexgenrx
Price$0.20
Change+$0.01 (+5.26%)
Volume$15K
Capitalization12.53M
NeueHealth
Price$6.85
Change-$0.00 (-0.00%)
Volume$1.06K
Capitalization52M
NEGXF vs NEUE Comparison Chart
Loading...
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEGXF vs. NEUE commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEGXF is a Hold and NEUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (NEGXF: $0.20 vs. NEUE: $6.85)
Brand notoriety: NEGXF and NEUE are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: NEGXF: 100% vs. NEUE: 16%
Market capitalization -- NEGXF: $12.53M vs. NEUE: $52M
NEGXF [@Managed Health Care] is valued at $12.53M. NEUE’s [@Managed Health Care] market capitalization is $52M. The market cap for tickers in the [@Managed Health Care] industry ranges from $451.47B to $0. The average market capitalization across the [@Managed Health Care] industry is $68.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEGXF’s FA Score shows that 1 FA rating(s) are green whileNEUE’s FA Score has 1 green FA rating(s).

  • NEGXF’s FA Score: 1 green, 4 red.
  • NEUE’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUE is a better buy in the long-term than NEGXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUE’s TA Score shows that 2 TA indicator(s) are bullish.

  • NEUE’s TA Score: 2 bullish, 4 bearish.

Price Growth

NEGXF (@Managed Health Care) experienced а 0.00% price change this week, while NEUE (@Managed Health Care) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +0.28%. For the same industry, the average monthly price growth was +1.37%, and the average quarterly price growth was -1.04%.

Industries' Descriptions

@Managed Health Care (+0.28% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUE($52M) has a higher market cap than NEGXF($12.5M). NEGXF YTD gains are higher at: 0.000 vs. NEUE (-7.682).
NEGXFNEUENEGXF / NEUE
Capitalization12.5M52M24%
EBITDA3.12MN/A-
Gain YTD0.000-7.682-
P/E Ratio7.29N/A-
Revenue12.6MN/A-
Total Cash1.79MN/A-
Total Debt637KN/A-
FUNDAMENTALS RATINGS
NEGXF: Fundamental Ratings
NEGXF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
78
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUE
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 27 days ago
89%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTRX12.17-0.12
-0.98%
Matrix Service Company
RDW19.08-0.24
-1.24%
Redwire Corp
DE509.59-7.27
-1.41%
Deere & Company
VOYA66.40-1.71
-2.51%
Voya Financial
RGC595.10-15.40
-2.52%
Regencell Bioscience Holdings Limited

NEGXF and

Correlation & Price change

A.I.dvisor tells us that NEGXF and ALHC have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEGXF and ALHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEGXF
1D Price
Change %
NEGXF100%
N/A
ALHC - NEGXF
5%
Poorly correlated
-0.93%
NEUE - NEGXF
3%
Poorly correlated
N/A
OSCR - NEGXF
-1%
Poorly correlated
-2.72%
PFHO - NEGXF
-4%
Poorly correlated
N/A

NEUE and

Correlation & Price change

A.I.dvisor tells us that NEUE and CLOV have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEUE and CLOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUE
1D Price
Change %
NEUE100%
N/A
CLOV - NEUE
5%
Poorly correlated
-1.54%
CVS - NEUE
5%
Poorly correlated
+1.67%
NEGXF - NEUE
4%
Poorly correlated
N/A
ALHC - NEUE
3%
Poorly correlated
-0.93%
ELV - NEUE
3%
Poorly correlated
-0.43%
More